Dapagliflozin a glucose‐regulating drug with diuretic properties in subjects with type 2 diabetes
Work
Year: 2013
Type: article
Abstract: Sodium-glucose co-transporter 2 (SGLT2) reabsorbs glucose and sodium in the renal proximal tubule. Dapagliflozin, an SGLT2 inhibitor, targets hyperglycaemia in type 2 diabetes by increasing renal gluc... more
Source: Diabetes Obesity and Metabolism
Institutions University Medical Center Groningen, University of Groningen, Zimmer Biomet (United States)
Cites: 20
Cited by: 753
Related to: 10
FWCI: 26.36
Citation percentile (by year/subfield): 99.99
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $4,940